Skip to content
Press
  • 3 Mar 2026

    Citywire: HgCapital proves its business as usual after tech rout

  • 2 Mar 2026

    AJ Bell Money & Markets: Investment Trust Show: How fund managers handle “sin stocks”

  • 19 Feb 2026

    Citywire: RTW: We’re in the early innings of a biotech recovery

  • 6 Feb 2026

    Citywire: HgCapital rallies as it reassures investors and launches buybacks

  • 26 Jan 2026

    Portfolio Adviser: RTW Biotech’s Wong: GLP-1s are tackling the ‘largest pharmaceutical event the industry has ever seen’

  • 26 Jan 2026

    Financial Times: China’s labs pull ahead as global drugmakers invest in biotech pioneers

  • 20 Jan 2026

    Interactive investor: Funds and trusts four pros are buying and selling: Q1 2026

  • 22 Nov 2025

    Money Makers: Money Makers Podcast with Jim Strang

  • 31 Oct 2025

    City AM: City AM’s Rupert Hargreaves spoke with Pieter Staelens, portfolio manager of CVC Income & Growth Limited at the Cadarn Capital Investor Conference

Investor Portal

Exclusive access for professional investors

The Investor Portal provides professional investors with exclusive access to upcoming Cadarn events, detailed fund portfolio insights and associated fund materials. A dedicated information hub that offers an insight into our fund partners’ respective investment approaches, market insights and fund news.

Sign up

Cadarn Capital Ltd (FRN: 998015) is an appointed representative of Thornbridge Investment Management LLP (FRN: 713859) which is authorised and regulated by the Financial Conduct Authority